From Isabelle DECORTE, Head of Pharmaceutical Development & Operations, QP at Synerlab Développement, Orléans
Enjoy your reading!
WE ARE SYNERLAB, NICE TO MEET YOU
Glad to let you know more about SYNERLAB
INVESTMENTS FOR COMPLEX FORMULATIONS
Specialized in pre-formulation to industrialization pharma development, Synerlab Développement develops oral solid forms by taking into account the regulatory, technical, therapeutic, commercial and insutrial exigencies. In order to adapt to the new formulation challenges posed by the higher number of increasingly complex molecular entities, Synerlab Développement has acquired hot extrusion equipment. This technology improves the bioavailability of active ingredients by adapting its release profile. For the purpose of developing with limited amounts of active ingredients drugs of major therapeutic interest that require quick clinical evaluation, the contract manufacturer has acquired a filling system that allows the manufacture of low-close capsules of vials.